Invengene Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 1.51 Cr
- Company Age 1 Year 6 Months
- Last Filing with ROC 31 Mar 2024
About Invengene
Invengene Limited (IL) is a Public Limited Indian Non-Government Company incorporated in India on 02 August 2023 (One year and six months 25 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ankur Shah, Vaibhavi Shah, and Rikin Sanghvi serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U21002MH2023PLC407959
- Company No.
407959
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Aug 2023
- Date of AGM
30 May 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Invengene?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaibhavi Shah  | Director | 02-Aug-2023 | Current |
| Ankur Shah | Director | 02-Aug-2023 | Current |
| Rikin Sanghvi | Additional Director | 28-Aug-2024 | Current |
Financial Performance of Invengene.
Invengene Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Invengene?
In 2024, Invengene had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Inventia Healthcare LimitedAnkur Shah is a mutual person
Va3 Ventures LlpAnkur Shah and Vaibhavi Shah are mutual person
- Tpc Enterprise Private Limited
Ankur Shah and Vaibhavi Shah are mutual person
- Dostana Endeavours Foundation
Vaibhavi Shah is a mutual person
- River Square Advisory Services Llp
Rikin Sanghvi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Invengene?
Invengene has a workforce of 0 employees as of Dec 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Invengene, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invengene's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
